Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 85 to 88 of 88 entries
Sorted by: Best Match Show Resources per page
Lipid profile in acute stroke: A prospective study.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Shuaib A, Kalra J, Prasad M, Mantha S, Wallace K.
PMID: 26486709
J Stroke Cerebrovasc Dis. 1992;2(3):125-30. doi: 10.1016/S1052-3057(10)80220-4. Epub 2010 Jun 09.

The dramatic decline in the risk of stroke is most likely secondary to a better control of risk factors, especially hypertension. An increase in low-density lipoprotein (LDL) cholesterol or a decrease in high-density lipoprotein (HDL) cholesterol may be additional...

Cite
Shuaib A, Kalra J, Prasad M, et al. Lipid profile in acute stroke: A prospective study. J Stroke Cerebrovasc Dis. 2010;2(3):125-30doi: 10.1016/S1052-3057(10)80220-4.
Shuaib, A., Kalra, J., Prasad, M., Mantha, S., & Wallace, K. (1992). Lipid profile in acute stroke: A prospective study. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2(3), 125-30. https://doi.org/10.1016/S1052-3057(10)80220-4
Shuaib, A, et al. "Lipid profile in acute stroke: A prospective study." Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association vol. 2,3 (1992): 125-30. doi: https://doi.org/10.1016/S1052-3057(10)80220-4
Shuaib A, Kalra J, Prasad M, Mantha S, Wallace K. Lipid profile in acute stroke: A prospective study. J Stroke Cerebrovasc Dis. 1992;2(3):125-30. doi: 10.1016/S1052-3057(10)80220-4. Epub 2010 Jun 09. PMID: 26486709.
Copy Download .nbib Format: NLM
Targeting the Cholesterol Paradigm in the Risk Reduction for Atherosclerotic Cardiovascular Disease: Does the Mechanism of Action of Pharmacotherapy Matter for Clinical Outcomes?.

Journal of cardiovascular pharmacology and therapeutics

Zhou R, Stouffer GA, Smith SC.
PMID: 34138676
J Cardiovasc Pharmacol Ther. 2021 Nov;26(6):533-549. doi: 10.1177/10742484211023632. Epub 2021 Jun 17.

Hypercholesterolemia is a well-established risk factor for atherosclerotic cardiovascular disease (ASCVD). Low-density lipoprotein cholesterol (LDL-C) has been labeled as "bad" cholesterol and high-density lipoprotein cholesterol (HDL-C) as "good" cholesterol. The prevailing hypothesis is that lowering blood cholesterol levels, especially...

Cite
Zhou R, Stouffer GA, Smith SC. Targeting the Cholesterol Paradigm in the Risk Reduction for Atherosclerotic Cardiovascular Disease: Does the Mechanism of Action of Pharmacotherapy Matter for Clinical Outcomes?. J Cardiovasc Pharmacol Ther. 2021;26(6):533-549doi: 10.1177/10742484211023632.
Zhou, R., Stouffer, G. A., & Smith, S. C. (2021). Targeting the Cholesterol Paradigm in the Risk Reduction for Atherosclerotic Cardiovascular Disease: Does the Mechanism of Action of Pharmacotherapy Matter for Clinical Outcomes?. Journal of cardiovascular pharmacology and therapeutics, 26(6), 533-549. https://doi.org/10.1177/10742484211023632
Zhou, Ruihai, et al. "Targeting the Cholesterol Paradigm in the Risk Reduction for Atherosclerotic Cardiovascular Disease: Does the Mechanism of Action of Pharmacotherapy Matter for Clinical Outcomes?." Journal of cardiovascular pharmacology and therapeutics vol. 26,6 (2021): 533-549. doi: https://doi.org/10.1177/10742484211023632
Zhou R, Stouffer GA, Smith SC. Targeting the Cholesterol Paradigm in the Risk Reduction for Atherosclerotic Cardiovascular Disease: Does the Mechanism of Action of Pharmacotherapy Matter for Clinical Outcomes?. J Cardiovasc Pharmacol Ther. 2021 Nov;26(6):533-549. doi: 10.1177/10742484211023632. Epub 2021 Jun 17. PMID: 34138676.
Copy Download .nbib Format: NLM
Label-Free Higher Order Structure and Dynamic Investigation Method of Proteins in Solution Using an Enzymatic Reactor Coupled to Electrospray High-Resolution Mass Spectrometry Detection.

Journal of the American Society for Mass Spectrometry

Grifnée E, Kune C, Delvaux C, Quinton L, Far J, Mazzucchelli G, De Pauw E.
PMID: 34969249
J Am Soc Mass Spectrom. 2021 Dec 31; doi: 10.1021/jasms.1c00274. Epub 2021 Dec 31.

For decades, structural analysis of proteins have received considerable attention, from their sequencing to the determination of their 3D structures either in the free state (e.g., no host-guest system, apoproteins) or (non)covalently bound complexes. The elucidation of the 3D...

Cite
Grifnée E, Kune C, Delvaux C, et al. Label-Free Higher Order Structure and Dynamic Investigation Method of Proteins in Solution Using an Enzymatic Reactor Coupled to Electrospray High-Resolution Mass Spectrometry Detection. J Am Soc Mass Spectrom. 2021;doi: 10.1021/jasms.1c00274.
Grifnée, E., Kune, C., Delvaux, C., Quinton, L., Far, J., Mazzucchelli, G., & De Pauw, E. (2021). Label-Free Higher Order Structure and Dynamic Investigation Method of Proteins in Solution Using an Enzymatic Reactor Coupled to Electrospray High-Resolution Mass Spectrometry Detection. Journal of the American Society for Mass Spectrometry, . https://doi.org/10.1021/jasms.1c00274
Grifnée, Elodie, et al. "Label-Free Higher Order Structure and Dynamic Investigation Method of Proteins in Solution Using an Enzymatic Reactor Coupled to Electrospray High-Resolution Mass Spectrometry Detection." Journal of the American Society for Mass Spectrometry vol. (2021). doi: https://doi.org/10.1021/jasms.1c00274
Grifnée E, Kune C, Delvaux C, Quinton L, Far J, Mazzucchelli G, De Pauw E. Label-Free Higher Order Structure and Dynamic Investigation Method of Proteins in Solution Using an Enzymatic Reactor Coupled to Electrospray High-Resolution Mass Spectrometry Detection. J Am Soc Mass Spectrom. 2021 Dec 31; doi: 10.1021/jasms.1c00274. Epub 2021 Dec 31. PMID: 34969249.
Copy Download .nbib Format: NLM
Reduced Levels of ABCA1 Transporter Are Responsible for the Cholesterol Efflux Impairment in β-Amyloid-Induced Reactive Astrocytes: Potential Rescue from Biomimetic HDLs.

International journal of molecular sciences

Sierri G, Dal Magro R, Vergani B, Leone BE, Formicola B, Taiarol L, Fagioli S, Kravicz M, Tremolizzo L, Calabresi L, Re F.
PMID: 35008528
Int J Mol Sci. 2021 Dec 22;23(1). doi: 10.3390/ijms23010102.

The cerebral synthesis of cholesterol is mainly handled by astrocytes, which are also responsible for apoproteins' synthesis and lipoproteins' assembly required for the cholesterol transport in the brain parenchyma. In Alzheimer disease (AD), these processes are impaired, likely because...

Cite
Sierri G, Dal Magro R, Vergani B, et al. Reduced Levels of ABCA1 Transporter Are Responsible for the Cholesterol Efflux Impairment in β-Amyloid-Induced Reactive Astrocytes: Potential Rescue from Biomimetic HDLs. Int J Mol Sci. 2021;23(1)doi: 10.3390/ijms23010102.
Sierri, G., Dal Magro, R., Vergani, B., Leone, B. E., Formicola, B., Taiarol, L., Fagioli, S., Kravicz, M., Tremolizzo, L., Calabresi, L., & Re, F. (2021). Reduced Levels of ABCA1 Transporter Are Responsible for the Cholesterol Efflux Impairment in β-Amyloid-Induced Reactive Astrocytes: Potential Rescue from Biomimetic HDLs. International journal of molecular sciences, 23(1), . https://doi.org/10.3390/ijms23010102
Sierri, Giulia, et al. "Reduced Levels of ABCA1 Transporter Are Responsible for the Cholesterol Efflux Impairment in β-Amyloid-Induced Reactive Astrocytes: Potential Rescue from Biomimetic HDLs." International journal of molecular sciences vol. 23,1 (2021). doi: https://doi.org/10.3390/ijms23010102
Sierri G, Dal Magro R, Vergani B, Leone BE, Formicola B, Taiarol L, Fagioli S, Kravicz M, Tremolizzo L, Calabresi L, Re F. Reduced Levels of ABCA1 Transporter Are Responsible for the Cholesterol Efflux Impairment in β-Amyloid-Induced Reactive Astrocytes: Potential Rescue from Biomimetic HDLs. Int J Mol Sci. 2021 Dec 22;23(1). doi: 10.3390/ijms23010102. PMID: 35008528; PMCID: PMC8745016.
Copy Download .nbib Format: NLM
Showing 85 to 88 of 88 entries